Efficacy and Safety of Fast-Acting Insulin Aspart According to Baseline HbA1c in Adults with Type 2 Diabetes Treated with a Basal-Bolus Regimen

被引：0
|
作者：
Franek, Edward
Ekelund, Magnus
Thorisdottir, Olof
Jang, Hak Chul
Lalic, Katarina
Rathor, Naveen
Rose, Ludger
Gonzalez, Alfonso Soto
Silver, Robert J.
Lane, Wendy
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1034-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1034-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements
    Sesti, G.
    Lane, W.
    Ekelund, M.
    Thorisdottir, O.
    Jodar, E.
    Oviedo, A.
    Rathor, N.
    Senior, P.
    Franek, E.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S330 - S330
  • [2] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
    Bowering, Keith
    Bode, Bruce W.
    Harris, Stewart B.
    Piletic, Milivoj
    Babu, Vinay
    Dethlefsen, Claus
    Rodbard, Helena W.
    [J]. DIABETES, 2017, 66 : A253 - A253
  • [3] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [4] THE IMPACT OF BASELINE BMI AND HBA1C ON GLYCAEMIC CONTROL AFTER TREATMENT WITH MEALTIME FAST-ACTING INSULIN ASPART IN PEOPLE WITH TYPE 1 DIABETES
    Russell-Jones, D.
    Heller, S.
    Woo, V.
    Babu, V.
    Dethlefsen, C.
    Mathieu, C.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A136 - A137
  • [5] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Mealtime Fast-Acting Insulin Aspart in People with Type 1 Diabetes
    Russell-Jones, David
    Heller, Simon R.
    Woo, Vincent C.
    Babu, Vinay
    Dethlefsen, Claus
    Mathieu, Chantal
    [J]. DIABETES, 2017, 66 : A616 - A616
  • [6] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    [J]. DIABETOLOGIA, 2019, 62 : S10 - S11
  • [7] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    [J]. ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
  • [8] Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes management
    Qin, Guangjiong
    Gao, Yunhua
    Wu, Yan
    Zhang, Suohui
    Qiu, Yuqin
    Li, Fang
    Xu, Bai
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (02) : 221 - 227
  • [9] Efficacy and safety of fast-acting insulin aspart versus insulin aspart both in combination with insulin degludec with or without metformin in adults with diabetes
    Du, J.
    Wang, G. X.
    Wang, G.
    Liu, M.
    Thamattoor, U. K.
    Luan, Z. J.
    Alibegovic, A. C.
    Mu, Y. M.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S377 - S377
  • [10] Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
    Bowering, Keith
    Case, Christopher
    Harvey, John
    Reeves, Michael
    Sampson, Michael
    Strzinek, Robert
    Bretler, Ditte-Marie
    Bang, Rikke Beck
    Bode, Bruce W.
    [J]. DIABETES CARE, 2017, 40 (07) : 951 - 957
12345